Company Filing History:
Years Active: 2015-2016
Title: The Innovations of Jon Erik Brænden
Introduction
Jon Erik Brænden is a noted inventor based in Oslo, Norway. He holds two patents that showcase his significant contributions to the field of photodynamic therapy. His work demonstrates a clear commitment to advancing medical applications, particularly in the treatment and diagnosis of serious health conditions.
Latest Patents
Brænden's recent patents include innovations surrounding carboxylic acid ALA esters. The first patent details new derivatives of 5-aminolevulinic acid (5-ALA), focusing on their utilization as photosensitizing agents. The invention explores compounds of general formula I and their pharmaceutically acceptable salts, elaborating on methods for their preparation and their potential medical and cosmetic applications.
The second patent introduces a novel crystalline polymorph of hexyl-5-aminolevulinate hydrochloride, known as Form C. This compound serves as a precursor to photodynamic diagnosis and treatment for various metabolic diseases, including different types of cancers and inflammatory bowel diseases. The patent also outlines methods for preparing Form C and its application in pharmaceutical formulations.
Career Highlights
Currently, Brænden works with Photocure ASA, where he leverages his expertise to further develop innovative solutions in the pharmaceutical industry. His career reflects a deep involvement in research that not only aims to enhance therapeutic outcomes but also optimizes techniques in medical diagnosis.
Collaborations
Throughout his career, Brænden has collaborated with esteemed colleagues, including Colin Barry Charnock and Aslak Godal. These partnerships highlight the collaborative nature of research and innovation in the field, where shared knowledge can lead to groundbreaking advancements.
Conclusion
Jon Erik Brænden's inventions exemplify the intersection of science and medicine. His patents represent significant strides toward improving treatment methods for critical health issues, reinforcing the importance of continuous innovation in the medical field. Through his work, Brænden contributes to the broader goal of enhancing patient care and outcomes.